We are a research-based specialty
biopharma company determined
to give people worldwide a longer
and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more


Scandinavian Biopharma

Promising preliminary findings from a Phase 2b study of the oral vaccine ETVAX® against travelers’ diarrhea in Finnish travelers to Benin, West Africa

Today, Scandinavian Biopharma reports on encouraging new results from a Phase 2b study of the oral, inactivated vaccine candidate ETVAX® against enterotoxigenic Escherichia coli (ETEC), the most frequent cause of travelers’ diarrhea and e[...]
Read more

Scandinavian Biopharma

Scandinavian Biopharma recruits Anna Hill as Clinical Operations Manager

Scandinavian Biopharma is now strengthening its organization by recruiting Anna Hill to the new position as Clinical Operations Manager. The company is in late clinical development phase with several ongoing clinical studies for the ETEC vaccine[...]
Read more